ValuEngine upgraded shares of Molina Healthcare Inc (NYSE:MOH) from a hold rating to a buy rating in a report released on Thursday morning.
A number of other research analysts have also recently commented on the company. Zacks Investment Research upgraded Molina Healthcare from a sell rating to a hold rating in a research note on Monday, November 6th. Morgan Stanley boosted their price objective on Molina Healthcare from $68.00 to $89.00 and gave the stock an overweight rating in a research note on Friday, November 3rd. Jefferies Group LLC boosted their price objective on Molina Healthcare from $64.00 to $74.00 and gave the stock a hold rating in a research note on Friday, November 3rd. Wolfe Research upgraded Molina Healthcare from a market perform rating to an outperform rating in a research note on Monday, October 23rd. Finally, BMO Capital Markets assumed coverage on Molina Healthcare in a research note on Monday, October 16th. They issued a market perform rating and a $70.00 price target on the stock. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and six have assigned a buy rating to the company. Molina Healthcare presently has an average rating of Hold and an average price target of $64.30.
Molina Healthcare (NYSE MOH) traded up $0.30 during mid-day trading on Thursday, reaching $76.90. The company’s stock had a trading volume of 1,006,000 shares, compared to its average volume of 1,585,734. Molina Healthcare has a 1 year low of $42.56 and a 1 year high of $80.65. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.24 and a current ratio of 1.29. The stock has a market capitalization of $4,390.53, a P/E ratio of 23.88 and a beta of 0.91.
Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Thursday, November 2nd. The company reported ($1.62) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.23 by ($1.85). The firm had revenue of $5.03 billion for the quarter, compared to analysts’ expectations of $4.95 billion. Molina Healthcare had a negative net margin of 1.76% and a positive return on equity of 17.76%. Molina Healthcare’s revenue was up 10.7% on a year-over-year basis. During the same period last year, the firm posted $0.85 EPS. equities analysts predict that Molina Healthcare will post -3.88 earnings per share for the current fiscal year.
In related news, Director Daniel Cooperman sold 4,500 shares of the stock in a transaction that occurred on Tuesday, November 7th. The stock was sold at an average price of $78.79, for a total value of $354,555.00. Following the completion of the transaction, the director now directly owns 9,087 shares of the company’s stock, valued at approximately $715,964.73. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $60.00, for a total value of $60,000.00. The disclosure for this sale can be found here. Insiders have sold 368,458 shares of company stock valued at $24,010,639 over the last ninety days. Corporate insiders own 6.20% of the company’s stock.
A number of hedge funds have recently modified their holdings of MOH. LS Investment Advisors LLC grew its holdings in Molina Healthcare by 40.9% in the 2nd quarter. LS Investment Advisors LLC now owns 1,829 shares of the company’s stock worth $127,000 after buying an additional 531 shares in the last quarter. Meeder Asset Management Inc. acquired a new stake in Molina Healthcare in the second quarter worth approximately $136,000. Riverhead Capital Management LLC lifted its position in Molina Healthcare by 64.2% in the second quarter. Riverhead Capital Management LLC now owns 2,463 shares of the company’s stock worth $170,000 after purchasing an additional 963 shares during the period. Sabal Trust CO acquired a new stake in Molina Healthcare in the third quarter worth approximately $206,000. Finally, Bronfman E.L. Rothschild L.P. lifted its position in Molina Healthcare by 478.7% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 3,316 shares of the company’s stock worth $229,000 after purchasing an additional 2,743 shares during the period. 95.88% of the stock is owned by institutional investors and hedge funds.
About Molina Healthcare
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Molina Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.